Cooper Companies (The) (COO)

Nasdaq Health Care Health Care Supplies S&P 500
$62.36
-1.15 (-1.81%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$2.92
Diluted, last four reported quarters

Latest results, in brief

All COO 8-K briefs →
Sep 9, 4:34 PM ET

CooperCompanies ends strategic review, keeps CooperSurgical, lifts buyback to $3 billion

Positive earnings Written later 2.028.01

CooperCompanies said its strategic review is complete and the Board unanimously decided to retain CooperSurgical, while also expanding its share repurchase authorization from $2 billion to $3 billion. The same day it reported fiscal third-quarter results with revenue up 1% and non-GAAP diluted EPS up 4%, though GAAP EPS was lifted by a $307.2 million tax benefit.

  • Q3 revenue $1.066 billion, up 1%; non-GAAP diluted EPS $1.15, up 4% from $1.10
  • GAAP diluted EPS $2.24 versus $0.49, driven by a $307.2 million discrete tax benefit from a U.K. tax examination
  • Buyback authorization raised from $2 billion to $3 billion; about $1.5 billion remains available after $339.1 million repurchased in the quarter
  • Fiscal Q4 2026 non-GAAP diluted EPS guidance of $1.05 to $1.09; fiscal 2026 guidance of $4.51 to $4.55
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Jul 2026$1.07B+0.6% $2.24+357.1% $432.80M40.6%
Apr 2026$1.08B+7.9% $-0.40-190.9% -$77.90M-7.2%
Jan 2026$1.02B+6.2% $0.66+26.9% $130.80M12.8%
Oct 2025$1.07B+4.6% $0.42-28.8% $84.60M7.9%
Jul 2025$1.06B+5.7% $0.49-5.8% $98.30M9.3%
Apr 2025$1.00B+6.3% $0.44+0.0% $87.70M8.7%
Jan 2025$964.70M+3.6% $0.52+26.8% $104.30M10.8%
Oct 2024$1.02B+9.8% $0.59+37.2% $117.50M11.5%

From Cooper Companies (The)'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$4.09B+5.1% $1.87-4.6%9.2%
FY2024$3.90B+8.4% $1.96+32.4%10.1%
FY2023$3.59B+8.6% $1.48-23.7%8.2%
FY2022$3.31B+13.2% $1.94-96.7%11.7%
FY2021$2.92B+20.2% $59.16+1129.9%100.8%

Frequently asked questions

When is Cooper Companies (The)'s next earnings date?

Cooper Companies (The) has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Cooper Companies (The) earn last quarter?

For the quarter ended Jul 2026, Cooper Companies (The) reported diluted EPS of $2.24 (+357.1% year over year) on revenue of $1.07B (+0.6%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.